GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Cyclically Adjusted FCF per Share

Qiagen NV (Qiagen NV) Cyclically Adjusted FCF per Share : $1.32 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Qiagen NV's adjusted free cash flow per share for the three months ended in Mar. 2024 was $0.418. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $1.32 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Qiagen NV's average Cyclically Adjusted FCF Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Qiagen NV was 29.10% per year. The lowest was 2.80% per year. And the median was 17.30% per year.

As of today (2024-05-17), Qiagen NV's current stock price is $45.81. Qiagen NV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $1.32. Qiagen NV's Cyclically Adjusted Price-to-FCF of today is 34.70.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Qiagen NV was 80.62. The lowest was 29.55. And the median was 44.95.


Qiagen NV Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Qiagen NV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Cyclically Adjusted FCF per Share Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.75 0.93 1.21 1.28

Qiagen NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 1.24 1.26 1.28 1.32

Competitive Comparison of Qiagen NV's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted Price-to-FCF falls into.



Qiagen NV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qiagen NV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.418/128.5800*128.5800
=0.418

Current CPI (Mar. 2024) = 128.5800.

Qiagen NV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.201 99.240 0.260
201409 0.310 99.960 0.399
201412 0.215 99.050 0.279
201503 0.171 99.750 0.220
201506 0.181 100.230 0.232
201509 0.319 100.500 0.408
201512 0.197 99.730 0.254
201603 0.120 100.310 0.154
201606 0.316 100.260 0.405
201609 0.316 100.570 0.404
201612 0.317 100.710 0.405
201703 0.157 101.440 0.199
201706 0.167 101.370 0.212
201709 0.203 102.030 0.256
201712 0.192 101.970 0.242
201803 0.063 102.470 0.079
201806 0.378 103.100 0.471
201809 0.202 103.950 0.250
201812 0.279 103.970 0.345
201903 -0.477 105.370 -0.582
201906 0.206 105.840 0.250
201909 0.266 106.700 0.321
201912 0.268 106.800 0.323
202003 -0.053 106.850 -0.064
202006 0.056 107.510 0.067
202009 -0.220 107.880 -0.262
202012 0.891 107.850 1.062
202103 0.327 108.870 0.386
202106 0.489 109.670 0.573
202109 0.463 110.790 0.537
202112 0.643 114.010 0.725
202203 0.757 119.460 0.815
202206 0.602 119.050 0.650
202209 0.828 126.890 0.839
202212 0.348 124.940 0.358
202303 0.145 124.720 0.149
202306 0.359 125.830 0.367
202309 0.374 127.160 0.378
202312 0.443 126.450 0.450
202403 0.418 128.580 0.418

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Qiagen NV  (NYSE:QGEN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Qiagen NV's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=45.81/1.32
=34.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Qiagen NV was 80.62. The lowest was 29.55. And the median was 44.95.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Qiagen NV Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (Qiagen NV) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Executives
Prof. Dr. Elaine R. Mardis Supervisory Board
Roland Sackers Board of Directors
Thierry Bernard Board of Directors
Lawrence A. Rosen Supervisory Board